FDA inspection
Khaled Tawansy, MD: FDA inspection ending Aug 24, 2022
FDA inspection 1178139 · Voluntary Action Indicated (VAI) · Los Angeles, CA
Key facts
| Inspection ID | 1178139 |
|---|---|
| Firm | Khaled Tawansy, MD |
| FEI number | 3023061364 |
| Address | 7447 N Figueroa St Ste 300 |
| City | Los Angeles |
| State | CA |
| ZIP | 90041 |
| Country | United States |
| Fiscal year | 2022 |
| Inspection end date | Aug 24, 2022 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data